Integra LifeSciences Holdings Corporation
IART
$9.55
-$0.02-0.21%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 8.17% | -3.26% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 8.17% | -3.26% | |||
| Cost of Revenue | 10.20% | -7.61% | |||
| Gross Profit | 6.66% | 0.28% | |||
| SG&A Expenses | 0.59% | -2.41% | |||
| Depreciation & Amortization | 1.07% | -0.69% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.15% | -5.42% | |||
| Operating Income | 35.63% | 22.09% | |||
| Income Before Tax | 163.16% | 98.71% | |||
| Income Tax Expenses | 523.52% | 96.97% | |||
| Earnings from Continuing Operations | 68.47% | 98.88% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 68.47% | 98.88% | |||
| EBIT | 35.63% | 22.09% | |||
| EBITDA | 18.01% | 11.44% | |||
| EPS Basic | 68.47% | 98.88% | |||
| Normalized Basic EPS | 53.44% | 41.60% | |||
| EPS Diluted | 67.33% | 98.88% | |||
| Normalized Diluted EPS | 53.44% | 41.60% | |||
| Average Basic Shares Outstanding | 0.03% | 0.08% | |||
| Average Diluted Shares Outstanding | 0.03% | 0.08% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||